LC. da Silva, H. Sette; DA. Chamone; A. Sáez-Alquezar; JA. Punskas; S. Raia, Further clinical trials with oxamniquine (UK 4271), a new anti-schistosomal agent., in Rev Inst Med Trop Sao Paulo, vol. 17, n. 5, pp. 307-11, PMID 1198006.
L. Pica-Mattoccia, D. Cioli; S. Archer, Binding of oxamniquine to the DNA of schistosomes., in Trans R Soc Trop Med Hyg, vol. 83, n. 3, pp. 373-6, PMID 2617584.
TK. Daneshmend, MA. Homeida, Oxamniquine pharmacokinetics in hepatosplenic schistosomiasis in the Sudan., in J Antimicrob Chemother, vol. 19, n. 1, Gen 1987, pp. 87-93, PMID 3104279.
AC. Sleigh, R. Hoff; KE. Mott; JH. Maguire; JT. da França Silva, Manson's schistosomiasis in Brazil: 11-year evaluation of successful disease control with oxamniquine., in Lancet, vol. 1, n. 8482, Mar 1986, pp. 635-7, PMID 2869344.
AM. Polderman, B. Gryseels; P. De Caluwe, Cure rates and egg reduction in treatment of intestinal schistosomiasis with oxamniquine and praziquantel in Maniema, Zaire., in Trans R Soc Trop Med Hyg, vol. 82, n. 1, 1988, pp. 115-6, PMID 3140441.
P. Jordan, Oxamniquine and fever., in Br Med J, vol. 2, n. 6201, Nov 1979, pp. 1366-7, PMID 519455.
GI. Higashi, Z. Farid, Oxamniquine fever--drug-induced or immune-complex reaction?, in Br Med J, vol. 2, n. 6194, Ott 1979, p. 830, PMID 509115.
ZA. Andrade, HA. dos Santos; JA. Grimaud, The liver after oxamniquine treatment of schistosomiasis., in Rev Inst Med Trop Sao Paulo, vol. 22, 1 Suppl 4, pp. 37-40, 153-6, PMID 7455508.
H. Stokvis, AG. Bauer; PC. Stuiver; AD. Malcolm; D. Overbosch, Seizures associated with oxamniquine therapy., in Am J Trop Med Hyg, vol. 35, n. 2, Mar 1986, pp. 330-1, PMID 3082231.
S. Krajden, JS. Keystone; C. Glenn, Safety and toxicity of oxamniquine in the treatment of Schistosoma mansoni infections, with particular reference to electroencephalographic abnormalities., in Am J Trop Med Hyg, vol. 32, n. 6, Nov 1983, pp. 1344-6, PMID 6650735.
SA. de Carvalho, MA. Shikanai-Yasuda; V. Amato Neto; M. Shiroma; FJ. Luccas, [Neurotoxicity of oxamniquine in the treatment of human Schistosoma mansoni infection]., in Rev Inst Med Trop Sao Paulo, vol. 27, n. 3, pp. 132-42, PMID 3938063.
JC. Guitti, LN. Gordan; JL. Baldy, [Cardiac arrhythmia with oral oxamniquine use in the schistosomiasis mansoni treatment]., in Rev Inst Med Trop Sao Paulo, vol. 35, n. 6, pp. 585-7, PMID 7997766.
R. Foster, A review of clinical experience with oxamniquine., in Trans R Soc Trop Med Hyg, vol. 81, n. 1, 1987, pp. 55-9, PMID 3127959.
IM. Abdel Rahim, AA. Haridi; AA. Abdel-Hameed, Field study of different oxamniquine dose for Schistosoma mansoni in Gezira, Sudan., in J Trop Med Hyg, vol. 91, n. 3, Giu 1988, pp. 131-7, PMID 3134556.
B. Gryseels, L. Nkulikyinka, Two-year follow-up of Schistosoma mansoni infection and morbidity after treatment with different regimens of oxamniquine and praziquantel., in Trans R Soc Trop Med Hyg, vol. 83, n. 2, pp. 219-28, PMID 2514474.